Eriodictyol Suppresses Gastric Cancer Cells via Inhibition of PI3K/AKT Pathway

Eriodictyol Suppresses Gastric Cancer Cells via Inhibition of PI3K/AKT Pathway

Gastric cancer (GC) is among the five most common malignancies worldwide. Traditional chemotherapy cannot efficiently treat the disease and faces the problems of side effects and chemoresistance. <i>Polygoni orientalis</i> Fructus (POF), with flavonoids as the main bioactive compounds, e...

Full description

Bibliographic Details
Main Authors: Hui Shan, Xin Zhang, Yalu Mi, Jihui Jia, Bo Wang, Qing Yang
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Pharmaceuticals
Subjects:
eriodictyol
<i>Polygoni orientalis</i> Fructus
gastric cancer
apoptosis
PI3K/AKT
network pharmacology
Online Access:https://www.mdpi.com/1424-8247/15/12/1477

Internet

https://www.mdpi.com/1424-8247/15/12/1477

Similar Items